|
artificial intelligence |
17 |
|
oral cancer |
17 |
|
machine learning |
14 |
|
oral leukoplakia |
11 |
|
oral lichenoid lesions |
11 |
|
animals |
9 |
|
rabbits |
9 |
|
oral potentially malignant disorders |
8 |
|
osteogenesis, distraction |
8 |
|
screening |
8 |
|
humans |
7 |
|
nicotine |
7 |
|
osteogenesis, distraction - methods |
7 |
|
zoledronic acid |
7 |
|
bone healing |
6 |
|
bone regeneration - drug effects |
6 |
|
distraction osteogenesis |
6 |
|
models, animal |
6 |
|
osteogenesis |
6 |
|
angiogenesis |
5 |
|
animal model |
5 |
|
bisphosphonate-related osteonecrosis of the jaws |
5 |
|
bone |
5 |
|
female |
5 |
|
graft versus host disease |
5 |
|
immunohistochemistry |
5 |
|
male |
5 |
|
mandible - drug effects - radiography - surgery |
5 |
|
mandible - pathology - radiation effects - surgery |
5 |
|
nicotine - pharmacology |
5 |
|
osteogenesis - drug effects |
5 |
|
ovariectomy |
5 |
|
periodontitis |
5 |
|
rampant caries |
5 |
|
random allocation |
5 |
|
rat |
5 |
|
risk model |
5 |
|
silver diamine fluoride |
5 |
|
time factors |
5 |
|
x-ray microtomography |
5 |
|
animal |
4 |
|
animal experiment |
4 |
|
biomaterials |
4 |
|
bone morphogenetic protein 2 |
4 |
|
bone regeneration - drug effects - physiology |
4 |
|
bone regeneration - physiology |
4 |
|
bone remodeling - drug effects |
4 |
|
cell culture |
4 |
|
chemicals and cas registry numbers |
4 |
|
connective tissue - drug effects - pathology |
4 |
|
delayed-action preparations |
4 |
|
dental implant |
4 |
|
disease models, animal |
4 |
|
distraction |
4 |
|
fluoride |
4 |
|
implants |
4 |
|
implants and osteoblasts/osteoclasts |
4 |
|
mandible |
4 |
|
micro-ct |
4 |
|
nicotine - adverse effects |
4 |
|
nicotinic agonists - adverse effects |
4 |
|
osteotomy - methods |
4 |
|
physical and radiology |
4 |
|
platelet count |
4 |
|
platelet-rich plasma - physiology |
4 |
|
proliferation |
4 |
|
rabbit |
4 |
|
radiation |
4 |
|
tissue engineering |
4 |
|
tomography, x-ray computed |
4 |
|
transforming growth factor beta1 - analysis |
4 |
|
vascular endothelial growth factor |
4 |
|
vascular endothelial growth factor a - genetics - metabolism |
4 |
|
wound healing - drug effects |
4 |
|
adolescence |
3 |
|
adolescent |
3 |
|
adult |
3 |
|
alveolar process - drug effects - physiology |
3 |
|
angiogenic mediator |
3 |
|
animal experiments |
3 |
|
animal tissue |
3 |
|
artifact |
3 |
|
biocompatible materials - therapeutic use |
3 |
|
biomechanics |
3 |
|
bmp |
3 |
|
bone augmentation |
3 |
|
bone defect |
3 |
|
bone density - radiation effects |
3 |
|
bone marrow - pathology - radiation effects |
3 |
|
bone matrix metalloproteinase |
3 |
|
bone morphogenetic protein 2 - genetics |
3 |
|
bone morphogenetic protein 7 - genetics |
3 |
|
bone morphogenetic protein-2 |
3 |
|
bone morphogenetic proteins - *analysis - radiation effects |
3 |
|
bone morphogenetic proteins - administration and dosage - pharmacology |
3 |
|
bone radiodensity |
3 |
|
bone regeneration - drug effects - genetics |
3 |
|
bone regeneration - radiation effects |
3 |
|
bone remodeling - radiation effects |
3 |
|
bone-implant interactions |
3 |
|
calcification, physiologic - radiation effects |
3 |
|
cancer |
3 |
|
caries |
3 |
|
chemotherapy |
3 |
|
child |
3 |
|
children |
3 |
|
chinese |
3 |
|
collagen type iv - metabolism |
3 |
|
ct imaging |
3 |
|
decision making |
3 |
|
deep learning |
3 |
|
dental implants. |
3 |
|
distraction rate |
3 |
|
dose fractionation |
3 |
|
dose-response relationship, radiation |
3 |
|
early diagnosis, precancerous conditions |
3 |
|
fibroblast growth factor 2 - *analysis - radiation effects |
3 |
|
gene expression - drug effects |
3 |
|
gene expression regulation - drug effects |
3 |
|
guided tissue regeneration |
3 |
|
guided tissue regeneration, periodontal - methods |
3 |
|
mandible - *radiation effects - surgery |
3 |
|
mandible - drug effects - pathology - surgery |
3 |
|
matrix metalloproteinase 1 - drug effects |
3 |
|
membranes, artificial |
3 |
|
mesenchymal stem cell transplantation - methods |
3 |
|
mesenchymal stromal cells - enzymology |
3 |
|
middle aged |
3 |
|
morphometric analysis |
3 |
|
mucositis |
3 |
|
oral squamous cell carcinoma |
3 |
|
osteoblast |
3 |
|
osteogenesis - radiation effects |
3 |
|
osteogenic mediator |
3 |
|
osteotomy |
3 |
|
placebos |
3 |
|
preoperative care |
3 |
|
protease inhibitors - pharmacology |
3 |
|
radiology |
3 |
|
radiotherapy dosage |
3 |
|
recombinant proteins - administration and dosage - pharmacology |
3 |
|
resorbable membrane |
3 |
|
third molars |
3 |
|
tissue inhibitor of matrix metalloproteinase |
3 |
|
tissue inhibitor of metalloproteinase-1 - pharmacology |
3 |
|
transfection |
3 |
|
transforming growth factor beta1 - antagonists and inhibitors |
3 |
|
treatment |
3 |
|
treatment outcome |
3 |
|
vascular endothelial growth factor a - analysis - radiation effects |
3 |
|
3d bioprinting |
2 |
|
3d printing |
2 |
|
4-1bbl |
2 |
|
4d printing |
2 |
|
actinomyces naeslundii |
2 |
|
aged |
2 |
|
ankylosis - etiology - pathology - physiopathology |
2 |
|
ankylosis - surgery |
2 |
|
antigens, cd - genetics - therapeutic use |
2 |
|
antigens, cd31 - metabolism |
2 |
|
arthroplasty |
2 |
|
arthroplasty - adverse effects - methods |
2 |
|
asymptomatische schleimhautveränderung |
2 |
|
automatic driven |
2 |
|
automation - instrumentation |
2 |
|
b7 antigens |
2 |
|
b7-h3 |
2 |
|
basic fibroblast growth factor |
2 |
|
beta-defensins - drug effects - immunology - metabolism |
2 |
|
biochemistry |
2 |
|
biology |
2 |
|
bisphosphonates-related osteonecrosis of the jaws |
2 |
|
blood perfusion |
2 |
|
blood vessels - drug effects |
2 |
|
bone and bones - blood supply - drug effects - pathology - radiography |
2 |
|
bone density |
2 |
|
bone morphogenetic protein 2 - analysis |
2 |
|
bone morphogenetic protein 2 - genetics - metabolism |
2 |
|
bone morphogenetic protein 4 |
2 |
|
bone morphogenetic protein 7 |
2 |
|
bone morphogenetic proteins |
2 |
|
bone morphogenetic proteins - analysis - metabolism |
2 |
|
bone morphogenetic proteins - genetics - metabolism |
2 |
|
bone regeneration |
2 |
|
bone remodeling |
2 |
|
bone remodeling - physiology |
2 |
|
bone resorption - pathology - radiography |
2 |
|
bone structure |
2 |
|
bone transplantation - adverse effects - methods |
2 |
|
bone transplantation - methods |
2 |
|
bones - growth. |
2 |
|
calcinosis - pathology - physiopathology |
2 |
|
cancer therapy |
2 |
|
cancer vaccines - genetics - therapeutic use |
2 |
|
carcinoma, squamous cell - drug therapy - immunology |
2 |
|
carcinoma, squamous cell - immunology - pathology |
2 |
|
cartilage - transplantation |
2 |
|
cd8t cell |
2 |
|
cell line |
2 |
|
cell line, tumor |
2 |
|
cell proliferation |
2 |
|
cell-laden hydrogel |
2 |
|
child, preschool |
2 |
|
clinicoradiography |
2 |
|
collagen |
2 |
|
continuous distraction |
2 |
|
controlled release |
2 |
|
controlled study |
2 |
|
core/shell scaffolds |
2 |
|
covid-19 |
2 |
|
diagnosis |
2 |
|
diagnosis, differential |
2 |
|
diclofenac |
2 |
|
distraction frequency |
2 |
|
drug carriers |
2 |
|
dual release |
2 |
|
electrospinning |
2 |
|
endoscopy |
2 |
|
epithelial and mesenchymal human tongue cancer cell |
2 |
|
estrogen deficiency |
2 |
|
experimental metastasis |
2 |
|
face - abnormalities |
2 |
|
fibroblast growth factor 2 - genetics - metabolism |
2 |
|
fibroma, ossifying - diagnosis - pathology - surgery |
2 |
|
fluorescence-labelled cancer cell |
2 |
|
fracture healing - drug effects |
2 |
|
frequency of distraction |
2 |
|
gene expression regulation - physiology |
2 |
|
goats |
2 |
|
granulocyte-colony stimulating factor |
2 |
|
growth factor |
2 |
|
hemangioma |
2 |
|
hemangioma - therapy |
2 |
|
histology |
2 |
|
human tongue cancer |
2 |
|
hypoxia inducible factor 1α |
2 |
|
hypoxia-inducible factor 1, alpha subunit - genetics - metabolism |
2 |
|
infant |
2 |
|
infant, newborn |
2 |
|
interferons - biosynthesis |
2 |
|
juvenile cemento-ossifying fibroma |
2 |
|
laser |
2 |
|
laser therapy - methods |
2 |
|
lentiviral transduction |
2 |
|
lipopolysaccharides - metabolism - pharmacology |
2 |
|
loading |
2 |
|
lymphangiogenesis - drug effects - physiology |
2 |
|
lymphatic metastasis |
2 |
|
malignant transformation |
2 |
|
maligne transformation |
2 |
|
malocclusion - surgery |
2 |
|
mandible - blood supply - drug effects - pathology - radiography |
2 |
|
mandible - blood supply - physiology - surgery |
2 |
|
mandible - blood supply - radiography - surgery |
2 |
|
mandible - cytology - metabolism - surgery |
2 |
|
mandible - drug effects - pathology - radiography - surgery |
2 |
|
mandible - growth and development - radiography - surgery |
2 |
|
mandible - growth. |
2 |
|
mandible - surgery |
2 |
|
mandibular advancement - instrumentation |
2 |
|
mandibular condyle - pathology - physiopathology |
2 |
|
maxilla |
2 |
|
maxilla - abnormalities - surgery |
2 |
|
maxillary neoplasms - diagnosis - pathology - surgery |
2 |
|
messenger rna |
2 |
|
meta-analysis |
2 |
|
micro-computed tomography |
2 |
|
microvessels - anatomy & histology - growth & development - metabolism |
2 |
|
models, biological |
2 |
|
mouth neoplasms - drug therapy - immunology |
2 |
|
mouth neoplasms - immunology - pathology |
2 |
|
mouth neoplasms - therapy |
2 |
|
multifunctional scaffolds |
2 |
|
multilayer film |
2 |
|
neoplasm invasiveness |
2 |
|
neovascularization, physiologic - drug effects - genetics |
2 |
|
neovascularization, physiologic - physiology |
2 |
|
nicotine - administration and dosage - blood - pharmacology |
2 |
|
nicotinic agonists - administration and dosage - blood - pharmacology |
2 |
|
non-steroidal anti-inflammatory drugs |
2 |
|
oral cavity |
2 |
|
oral lesions |
2 |
|
oral lichen planus |
2 |
|
oral manifestations |
2 |
|
oral mucosal lesions |
2 |
|
oral surgical procedures - methods |
2 |
|
orales plattenepithelkarzinom |
2 |
|
osseointegration |
2 |
|
osteogenesis - genetics |
2 |
|
osteogenesis - physiology |
2 |
|
osteogenesis, distraction - instrumentation |
2 |
|
osteogenesis, distraction - instrumentation - methods |
2 |
|
osteoporosis |
2 |
|
parecoxib |
2 |
|
perfusion |
2 |
|
periodontal diseases |
2 |
|
phenotypic stability |
2 |
|
postoperative cancer management |
2 |
|
primary oral cancer cell |
2 |
|
protease inhibitors - therapeutic use |
2 |
|
rabbits as laboratory animals. |
2 |
|
radiography, panoramic |
2 |
|
range of motion, articular - physiology |
2 |
|
rat model |
2 |
|
receptor, epidermal growth factor - metabolism |
2 |
|
receptors, immunologic - genetics - therapeutic use |
2 |
|
recombinant human bone morphogenetic protein-2 |
2 |
|
recombinant proteins |
2 |
|
recombinant proteins - metabolism |
2 |
|
reconstructive surgical procedures - methods |
2 |
|
recurrence |
2 |
|
references (9) view in table layout |
2 |
|
rna, messenger - analysis |
2 |
|
rna, messenger - genetics - metabolism |
2 |
|
sars-cov-2 |
2 |
|
schlagwörter: oraler lichen planus |
2 |
|
sensitivity and specificity |
2 |
|
shape morphing |
2 |
|
signal transduction - immunology - physiology |
2 |
|
stable cell labelling |
2 |
|
statistics, nonparametric |
2 |
|
symptomatische schleimhautveränderung |
2 |
|
systemic review |
2 |
|
t-lymphocytes, cytotoxic - immunology - metabolism |
2 |
|
temporomandibular joint disc - pathology - physiopathology |
2 |
|
temporomandibular joint disorders - etiology - pathology - physiopathology |
2 |
|
temporomandibular joint disorders - surgery |
2 |
|
theranostics |
2 |
|
tissue inhibitor of metalloproteinase-1 - therapeutic use |
2 |
|
tomography, spiral computed |
2 |
|
torque |
2 |
|
trabecular bone |
2 |
|
traction - instrumentation - methods |
2 |
|
transforming growth factor beta - analysis - metabolism |
2 |
|
transforming growth factor beta - genetics - metabolism |
2 |
|
transgenes |
2 |
|
tumor cells, cultured |
2 |
|
uterine regeneration |
2 |
|
uterine tissue engineering |
2 |
|
vascular malformation |
2 |
|
vascular malformations - therapy |
2 |
|
wound healing |
2 |
|
wound healing - drug effects - genetics |
2 |
|
wound healing - physiology |
2 |
|
actinomyces |
1 |
|
adenoma - diagnosis - therapy |
1 |
|
adhesives |
1 |
|
allografts |
1 |
|
alloplastic grafts |
1 |
|
alveolar bone loss |
1 |
|
anemia |
1 |
|
angiogenic markers |
1 |
|
animal cell |
1 |
|
barrier membrane |
1 |
|
bfgf |
1 |
|
bone morphogenetic proteins - genetics - pharmacology - therapeutic use |
1 |
|
bone remodeling - drug effects - physiology |
1 |
|
cartilage |
1 |
|
ceramics |
1 |
|
chinese medicine |
1 |
|
dna-binding proteins - metabolism |
1 |
|
drugs, chinese herbal - classification - therapeutic use |
1 |
|
drugs, chinese herbal - therapeutic use |
1 |
|
endothelial cells |
1 |
|
endothelial cells - metabolism |
1 |
|
evidence-based dentistry - methods |
1 |
|
fibroblast growth factor 2 - biosynthesis |
1 |
|
gene expression |
1 |
|
gene therapy |
1 |
|
glossodynia |
1 |
|
hedgehog signaling |
1 |
|
hemangioma, capillary - metabolism |
1 |
|
herbology |
1 |
|
histocytochemistry |
1 |
|
infantile haemangiomas |
1 |
|
intraflagellar transport protein 88 |
1 |
|
ion channels |
1 |
|
kinetics |
1 |
|
lichen planus, oral |
1 |
|
lingual thyroid - pathology - surgery |
1 |
|
lip diseases - complications - drug therapy - pathology |
1 |
|
lmo2 |
1 |
|
macrophages |
1 |
|
mandible - drug effects - metabolism - physiopathology - radiography - surgery |
1 |
|
mandibular condylar chondrocytes |
1 |
|
mechanotransduction |
1 |
|
medication-related osteonecrosis of the jaw |
1 |
|
medication-related osteonecrosis of the jaws |
1 |
|
medicine, chinese traditional - methods |
1 |
|
metalloproteins - metabolism |
1 |
|
mouth - surgery |
1 |
|
mouth diseases - drug therapy |
1 |
|
oral |
1 |
|
oral disease |
1 |
|
oral manifestation |
1 |
|
oropharyngeal neoplasms - diagnosis |
1 |
|
osteoarthritis |
1 |
|
osteogenesis - drug effects - physiology |
1 |
|
periapical diseases |
1 |
|
phytotherapy |
1 |
|
piezo2 |
1 |
|
polycystin 2 |
1 |
|
primary cilia |
1 |
|
rapamycin |
1 |
|
recombinant adeno-associated virus 2 |
1 |
|
recombinant proteins - pharmacology |
1 |
|
salvia miltiorrhiza |
1 |
|
scleroderma, localized - complications - drug therapy - pathology |
1 |
|
sialoadenitis |
1 |
|
sjogren's syndrome |
1 |
|
steroids |
1 |
|
tacrolimus |
1 |
|
temporomandibular joint |
1 |
|
tendon |
1 |
|
thyroid diseases - congenital |
1 |
|
tongue - anatomy & histology - pathology |
1 |
|
total glucosides of paeony |
1 |
|
transforming growth factor beta - genetics - pharmacology - therapeutic use |
1 |
|
trigeminal ganglion |
1 |
|
vitamin b12 deficiency |
1 |
|
ym155 |
1 |
|
“beefy red” patch |
1 |
